RXII


Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Provides an Update on Series A and Series A-1 Preferred Stock

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today provided …

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Reports First Quarter 2015 Financial Results and Business Highlights

 RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in the areas      of dermatology and …

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Presented Promising New Data with Self-delivering RNAi Compounds Targeting Tyrosinase and Collagenase

  RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and  ophthalmology, …

Looking Ahead of Wall Street: RXI Pharmaceuticals Corp, Titan Pharmaceuticals, Inc., Micron Technologies, Inc.

It’s an exciting week ahead for the biotech and technology sectors as three big players are scheduled to announce their quarterly financial results. …

RXi Pharmaceuticals: A Nearly 40% Sell-Off Creates A Unique Buying Opportunity, Says H.C. Wainwright

In a research report issued yesterday, H.C.

H.C. Wainwright Reiterates Buy On RXi Pharmaceuticals Following 2Q14 Update

In a research note published today, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts